Comprehensive Strategy for Heart Failure Management: Reducing Rehospitalization and Improving Patient Outcomes
Source: Comprehensive Strategy for Heart Failure Management: Reducing Rehospitalization and Improving Patient Outcomes

Video Module

In this CME-certified video module, Keith C. Ferdinand, MD, FACC, FAHA, discusses approaches to recognizing patients with elevated HF risk, using biomarkers to support HF diagnosis and prognosis, and integrating the latest treatment options into evidence-based management therapies, with a focus on treating special patient populations.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Accurately diagnose HF subtypes and predict outcomes with optimal use of available tools
  • Initiate evidence-based treatment strategies for HF based on identified patient risk factors and select treatment options that maximize use of conventional and newer treatment options to reduce hospitalizations and improve outcomes
  • Evaluate clinical data on emerging treatment options for the management of HF
  • Identify physiologic, economic, and cultural barriers that affect treatment of HF in black patients, women, and the elderly and initiate appropriate interventions to optimize outcomes in the underserved patient populations
CCO Video Modules contain video commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.
 

Faculty

  • Keith C. Ferdinand
    MD, FACC, FAHA

Credit Information

  • Release Date:
    August 31, 2016
  • Expiration Date:
    August 30, 2017
  • Physicians:
    maximum of 0.75 AMA PRA Category 1 Credits

Information on this Educational Activity

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Faculty

Keith C. Ferdinand, MD, FACC, FAHA


Professor of Medicine
Tulane Heart and Vascular Institute
Tulane University School of Medicine
New Orleans, Louisiana

Keith C. Ferdinand, MD, FACC, FAHA, has disclosed that he has received consulting fees from Amgen, Boehringer Ingelheim, and sanofi-aventis and funds for research support from Boehringer Ingelheim.
 

Staff

Ryan P. Topping, PhD


Associate Managing Editor

Ryan P. Topping, PhD, has no real or apparent conflicts of interest to report.
 

Jenny Schulz, PhD


Editorial Director, Virology & Other Therapeutic Areas

Jenny Schulz, PhD, has no real or apparent conflicts of interest to report.
 

Megan K. Murphy, PhD


Clinical Editor

Megan Murphy, PhD, has no real or apparent conflicts of interest to report.
 

Heather Stieglitz, PhD


Editorial Contributor

Heather Stieglitz, PhD, has no real or apparent conflicts of interest to report.
 

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

 

Target Audience

This program is intended for cardiologists, hospitalists, internists, family physicians, and other clinicians caring for patients with heart failure.


Goal

The goal of this activity is to close the knowledge and practice gaps in heart failure management by reducing events that ultimately result in rehospitalizations and deaths among patients with heart failure.


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Accurately diagnose HF subtypes and predict outcomes with optimal use of available tools
  • Initiate evidence-based treatment strategies for HF based on identified patient risk factors and select treatment options that maximize use of conventional and newer treatment options to reduce hospitalizations and improve outcomes
  • Evaluate clinical data on emerging treatment options for the management of HF
  • Identify physiologic, economic, and cultural barriers that affect treatment of HF in black patients, women, and the elderly and initiate appropriate interventions to optimize outcomes in the underserved patient populations
 

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Clinical Care Options, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Commercial Support


This program is supported by an educational grant from Novartis Pharmaceuticals Corporation.

 

Program Medium


This program has been made available online.

 

Site Requirements


  • Internet Explorer 7+, Firefox 3+, Safari 3+, or Chrome
  • JavaScript enabled
  • 1024x768+ screen resolution
  • Adobe Flash Player
 

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from August 31, 2016, through August 30, 2017:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME activities completed can be found on the "CME Manager" page. There are no costs/fees for this activity.